drugs

See the following -

FDA Seeks Data Mining Tool to Track Adverse Drug Reactions

Joseph Marks | NextGov | July 24, 2012

The Food and Drug Administration is in the market for a data mining tool that will gather information on adverse reactions to vaccines and other drugs, according to solicitation documents posted Monday. Read More »

FDA Takes Significant Steps To Address Antimicrobial Resistance

Press Release | Food and Drug Administration (FDA) | December 11, 2013

The U.S. Food and Drug Administration today is implementing a plan to help phase out the use of medically important antimicrobials in food animals for food production purposes, such as to enhance growth or improve feed efficiency. The plan would also phase in veterinary oversight of the remaining appropriate therapeutic uses of such drugs. Read More »

FDA Wants To Leverage Electronic Medical Records To Probe For Adverse Events

Alexander Gaffney | Regulatory Focus (RF) | January 6, 2014

Keeping track of adverse events is a tricky task, even for regulators. Even when a drug has undergone a rigorous premarket assessment process, some risks may not become evident until a product is used by millions. And for other drugs, a particularly rare but serious side effect may take months, if not years, to be identified. Read More »

FDA Wants To Use EMRs To Streamline Adverse Drug Event Reporting

Ashley Gold | FierceEMR | January 8, 2014

The U.S. Food and Drug Administration wants to leverage electronic medical records to probe for adverse drug events, according to a recent article in Regulatory Focus. Big data has the power to help expose adverse events more quickly than ever, and the FDA wants to use that to assess drug side effects. Read More »

Feeding A Disease With Fake Drugs

Roger Bate | New York Times | February 5, 2013

Thanks to billions of dollars spent on diagnosis and treatment [for tuberculosis] over the past decade, deaths and infections are slowly declining. Yet a disturbing phenomenon has emerged that could not only reverse any gains we’ve made, but also encourage the spread of a newly resistant form of the disease. Read More »

Free Drugs? India Mulls a New Assault on Big Pharma

Jason Overdorf | GlobalPost | June 25, 2012

...now it seems India is considering offering generic drugs for free to patients at government-run clinics. After Prime Minister Manmohan Singh backed the scheme, the Planning Commission has reportedly allocated $18 million to start the ball rolling.

Read More »

Genomics And Personalized Medicine Open Policy Forum

Press Release | Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine | June 4, 2013

Actress Angelina Jolie’s opinion piece in The New York Times this month highlighted the critical role genetic testing can play in cancer prevention – as well as the obstacles many face in securing that lifesaving knowledge. Read More »

Ghosts In The Criminal Machine - How A Drug Company Can Plead Guilty To Federal Fraud, Yet No One Is Held Responsible

Roy M. Poses | Health Care Renewal | May 28, 2013

We have often discussed how leaders of health care organizations have become increasingly unaccountable for their actions.  A recent, slightly obscure story shows how a corporate admission of guilt to a felony can be used to prevent anyone, including anyone in corporate management, from being held responsible for that fraud. Read More »

Giant GSK Settlement Provides Reminder of the Pervasiveness of Stealth Marketing

Roy M. Poses | Health Care Renewal | July 5, 2012

The latest  and biggest legal settlement involving health care to hit the news, that of GlaxoSmithKline (GSK) and the US government, has many familiar elements. [These documents] provide good documentation about how pervasive systematic, deceptive stealth marketing campaigns have become in health care. Read More »

Heroin Taking Oxy's Place For More Addicts

Nicole Brochu | Sun Sentinel | February 19, 2013

The state's war on pill mills is making an impact, but there's a troubling byproduct: a surge in the number of people now hooked on heroin. Read More »

How Clinical Guidelines Can Fail Both Doctors And Patients

Robert McNutt and Nortin Hadler | The Health Care Blog | December 11, 2013

Any confusion over the recent news of cholesterol guidelines in the U.S. is perfectly understandable. On the one hand, the guidelines suggest that nearly half the population should use statins to stave off heart attacks and strokes. On the other, use of the drugs is not with potential side effects and, to many, will offer no substantive benefits. [...] Read More »

How Scrutiny Of Freely Available Data Might Save The NHS Money

Staff Writer | The Economist | December 8, 2012

This week Britons were reminded yet again of the strains on the government’s finances. But another resource—data—is in abundant supply. Like governments in many other countries, Britain’s is turning more and more of its trove of information into “open data”... Read More »

IBM And University Scientists Launch Global Computing Effort To Find Cures For Dengue, West Nile, And Hepatitis C Diseases

Press Release | International Business Machines Corporation (IBM), University of Texas Medical Branch (UTMB) | August 23, 2007

Researchers Say the 50,000 Years of Computer Time Needed to Discover Cures May Be Achieved in One Year Using World Community Grid Read More »

IBM's Reinvention Should Inspire Flat Pharma Businesses

Dave Chase | Forbes | July 28, 2012

The pharmaceutical giants look remarkably similar to the IBM of the late 80′s and early 90′s. For those of us who remember the IBM of that era, this is bad news. Read More »

Indian Pharma Industry Should Work For Inventing New Drugs, Dr Abdul Kalam

Peethaambaran Kunnathoor | Pharmabiz.com | December 7, 2012

The Indian pharmaceutical industry should turn their attention to invent new drugs from molecule levels and each manufacturing unit should try to become invention centres, opined Dr APJ Abdul Kalam, former President of India. Read More »